Page results
-
Transforming UCLH into a truly digitally integrated hospital has paid dividends during our response to COVID-19. We are one of a handful of trusts to have done this.
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
Volunteers are being asked to sign up to the latest Covid-19 vaccine study to begin across the UK including at UCLH.
-
This page aims to support and supplement the information provided in the video titled Managing the Emotional Impact of Cancer, available on uclh.nhs.uk/wellbeing.
-
Dr Yen Ching Chang has been a consultant radiotherapist at UCLH since 2005. She has a specialist practice in paediatric radiotherapy (in particular neuro oncology and haematological malignancies) as well as in the late effects of childhood cancers and their treatment. Her research interests are Proton beam therapy, paediatric brian tumours, Hodgkins' lymphoma and late effects following childhood cancer.
-
UCLH runs a programme of GP education seminars designed to keep primary care teams updated with all our services and specialties.
-
From May 2021 north central London (NCL) has implemented a new model for elective orthopaedic care. This follows a review of adult elective orthopaedic services and is the culmination of three years collaboration with NHS providers to improve services for patients.
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided joint and soft tissue injections to patients referred by the Camden community MSK services.
-
Dr Saifee is a consultant neurologist with expertise in movement disorders. He has a particular interest in tremor, dystonia and Parkinson’s disease.
-
Dr Stephen Daw is a consultant paediatric and adolescent haemato-oncologist who specialises in treating children and young people with haematological malignancies. He has a particular interest in Hodgkin lymphoma and non-Hodgkin's lymphoma.
File results
-
FOI/2024/0702 - Community respiratory service mapping/ community-based bronchiectasis services
-
FOI/2024/0703 - Neurofibromatosis type 1 treatment/ volume of medication dispensed
-
FOI/2024/0704 - Contingencies to support visitors/ patients/ contractors witnessing a distressing event
-
FOI/2024/0716 - Toxicological screening/ testing/ training and information to patients
-
FOI/2024/0718 - Mental health/ electronic health records software/ dermatology screening/ imaging services/ medical devices for wound care
-
FOI/2024/0721 - New biologic and targeted medications/ treatment within dermatology
-
FOI/2024/0727 - Clinical photography solution contract/ spend
-
FOI/2024/0740 - A&E tooth decay admissions for 2021/22, 2022/23 and 2023/24
-
FOI/2024/0741 - HR, finance and payroll contracts/ software updates/ staff contact details
-
FOI/2024/0750 - Spend on law firms for services related to maternity and neonatal care 2021-2023